SCHEMBL4032086

SCHEMBL4032086

O=C(O)C1=C(O)CCc2cc(F)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 5/20 0.41
SRD5A2 P31213 3/20 0.39
HIF1A Q16665 2/20 0.39
TTR P02766 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
DHFR P00374 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
ALB P02768 1/20 0.39
HMGB1 P09429 1/20 0.39
HPGD P15428 1/20 0.39
CXCL12 P48061 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
ACMSD Q8TDX5 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL588072 0.81 MAPK14 (0.43) SRD5A1KDM4EALDH1A1LMNAHPGD
SCHEMBL4025662 0.80 SRD5A1 (0.61) SRD5A1SRD5A2ALDH1A1CA1CA2
SCHEMBL4030552 0.76 KDM4E (0.57) KDM4EMEN1ALDH1A1LMNAKMT2A
SCHEMBL6676615 0.75 SRD5A2 (0.51) SRD5A1SRD5A2KDM4EALDH1A1LMNA
SCHEMBL11685606 0.72 MAPK14 (0.60) SRD5A1SRD5A2TTRALDH1A1MAPK14
SCHEMBL11811771 0.70 SRD5A1 (0.50) SRD5A1SRD5A2KDM4EALDH1A1LMNA
SCHEMBL3372953 0.70 SRD5A1 (0.54) SRD5A1MAPK14CYP19A1CYP11B1CYP11B2
SCHEMBL7564636 0.70 CYP11B2 (0.51) SRD5A1CYP19A1CYP11B1CYP11B2
SCHEMBL7564639 0.70 CYP11B2 (0.51) SRD5A1CYP19A1CYP11B1CYP11B2
SCHEMBL7564643 0.70 CYP11B2 (0.51) SRD5A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747201-B8 2H OR 3H-BENZO[E]INDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2009-02-18 EP disclosed
EP-1747201-B1 2H OR 3H-BENZO[E]INDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2008-10-15 EP disclosed
EP-1747201-A1 2H OR 3H-BENZO[E]INDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2007-01-31 EP disclosed
WO-2005121099-A1 2H OR 3H-BENZO[E]INDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2005-12-22 WO disclosed